Aminoguanidine administration ameliorates hippocampal damage after middle cerebral artery occlusion in rat

Neurochemical Research

Volumn 36, Issue 3, 2011, Pages 476-486

  Danielisova, Viera ^a   Burda, Jozef ^a   Nemethova, Miroslava ^a   Gottlieb, Miroslav ^a  

^a INSTITUTE OF CHEMISTRY   (Slovakia)

Author keywords

Aminoguanidine; Cerebral ischemia; Hippocampus; iNOS

Indexed keywords

AMINOGUANIDINE;

ADULT ANIMAL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN DAMAGE; BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; BRAIN NERVE CELL; CELL SURVIVAL; CONTROLLED STUDY; DRUG EFFECT; HIPPOCAMPAL CA1 REGION; HIPPOCAMPUS DAMAGE; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; NERVE DEGENERATION; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; ENZYME INHIBITORS; GUANIDINES; HIPPOCAMPUS; INFARCTION, MIDDLE CEREBRAL ARTERY; ISCHEMIC ATTACK, TRANSIENT; MALE; NERVE DEGENERATION; NEURONS; NITRIC OXIDE SYNTHASE TYPE II; RATS; RATS, WISTAR;

ANIMALIA; RATTUS;

EID: 79954420117     PISSN: 03643190     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11064-010-0366-1     Document Type: Article

References (40)

1. Kirino T (1982) Delayed neuronal death in the gerbil hippocampus following ischemia. Brain Res 239:57-69. (Pubitemid 12101768)
2. Sasaki T, Hamada J, Shibata M, Araki N, Fukuuchi Y (2001) Inhibition of nitric oxide production during global ischemia ameliorates ischemic damage of pyramidal neurons in the hippocampus. Keio J Med 50:182-187. (Pubitemid 33607437)
3. Burda J, Hrehorovska M, Bonilla LG et al (2003) Role of protein synthesis in the ischemic tolerance acquisition induced by transient forebrain ischemia in the rat. Neurochem Res 28:1213-1219. (Pubitemid 36734553)
4. Burda J, Matiasova M, Gottlieb M et al (2005) Evidence for a role of second pathophysiological stress in prevention of delayed neuronal death in the hippocampal CA1 region. Neurochem Res 30:1397-1405. (Pubitemid 41784475)
5. Danielisova V, Nemethova M, Gottlieb M, Burda J (2005) Changes of endogenous antioxidant enzymes during ischemic tolerance acquisition. Neurochem Res 30:559-565. (Pubitemid 40933662)
6. Butler TL, Kassed CA, Sanberg PR, Willing AE, Pennypacker KR (2002) Neurodegeneration in the rat hippocampus and striatum after middle cerebral artery occlusion. Brain Res 929:252-260. (Pubitemid 34178341)
7. Corsani L, Bizzoco E, Pedata F et al (2008) Inducible nitric oxide synthase appears and is co-expressed with the neuronal isoform in interneurons of the rat hippocampus after transient ischemia induced by middle cerebral artery occlusion. Exp Neurol 211:433-440.
8. Sugimoto K, Iadecola C (2002) Effects of aminoguanidine on cerebral ischemia in mice: comparison between mice with and without inducible nitric oxide synthase gene. Neurosci Lett 331:25-28. (Pubitemid 35279374)
9. Cash D, Beech JS, Rayne RC, Bath PM, Meldrum BS, Williams SC (2001) Neuroprotective effect of aminoguanidine on transient focal ischaemia in the rat brain. Brain Res 905:91-103. (Pubitemid 32553842)
10. Nagayama M, Zhang F, Iadecola C (1998) Delayed treatment with aminoguanidine decreases focal cerebral ischemic damage and enhances neurologic recovery in rats. J Cereb Blood Flow Metab 18:1107-1113. (Pubitemid 28465358)
11. Zhang F, Iadecola C (1998) Temporal characteristics of the protective effect of aminoguanidine on cerebral ischemic damage. Brain Res 802:104-110. (Pubitemid 28392161)
12. Zhang F, Casey RM, Ross ME, Iadecola C (1996) Aminoguanidine ameliorates and L-arginine worsens brain damage from intraluminal middle cerebral artery occlusion. Stroke 27:317-323.
13. Danielisova V, Nemethova M, Burda J (2004) The protective effect of aminoguanidine on cerebral ischemic damage in the rat brain. Physiol Res 53:533-540. (Pubitemid 39486711)
14. Louin G, Marchand-Verrecchia C, Palmier B, Plotkine M, Jafarian-Tehrani M (2006) Selective inhibition of inducible nitric oxide synthase reduces neurological deficit but not cerebral edema following traumatic brain injury. Neuropharmacology 50:182-190. (Pubitemid 43100004)
15. Vakili A, Hosseinzadeh F, Sadogh T (2007) Effect of aminoguanidine on post-ischemic brain edema in transient model of focal cerebral ischemia. Brain Res 1170:97-102. (Pubitemid 47374656)
16. Lu J, Moochhala S, Shirhan M (2003) Neuroprotection by aminoguanidine after lateral fluid-percussive brain injury in rats: a combined magnetic resonance imaging, histopathologic and functional study. Neuropharmacology 44:253-263. (Pubitemid 36293265)
17. Dingman A, Lee SY, Derugin N, Wendland MF, Vexler ZS (2006) Aminoguanidine inhibits caspase-3 and calpain activation without affecting microglial activation following neonatal transient cerebral ischemia. J Neurochem 96:1467-1479.
18. Duckworth EA, Butler TL, De Mesquita D et al (2005) Temporary focal ischemia in the mouse: technical aspects and patterns of Fluoro-Jade evident neurodegeneration. Brain Res 1042:29-36.
19. Davoli MA, Fourtounis J, Tam J et al (2002) Immunohistochemical and biochemical assessment of caspase-3 activation and DNA fragmentation following transient focal ischemia in the rat. Neuroscience 115:125-136. (Pubitemid 35232694)
20. Sugawara T, Lewen A, Noshita N, Gasche Y, Chan PH (2002) Effects of global ischemia duration on neuronal, astroglial, oligodendroglial, and microglial reactions in the vulnerable hippocampal CA1 subregion in rats. J Neurotrauma 19:85-98. (Pubitemid 34126348)
21. Benedek A, Moricz K, Juranyi Z et al (2006) Use of TTC staining for the evaluation of tissue injury in the early phases of reperfusion after focal cerebral ischemia in rats. Brain Res 1116:159-165. (Pubitemid 44485008)
22. Liu F, Schafer DP, McCullough LD (2009) TTC, fluoro-Jade B and NeuN staining confirm evolving phases of infarction induced by middle cerebral artery occlusion. J Neurosci Methods 179:1-8.
23. Longa EZ, Weinstein PR, Carlson S, Cummins R (1989) Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke 20:84-91. (Pubitemid 19040218)
24. Bederson JB, Pitts LH, Germano SM et al (1986) Evaluation of 2, 3, 5-triphenyltetrazolium chloride as a stain for detection and quantification of experimental cerebral infarction in rats. Stroke 17:1304-1308. (Pubitemid 17008976)
25. Swanson RA, Morton MT, Tsao-Wu G et al (1990) A semiautomated method for measuring brain infarct volume. J Cereb Blood Flow Metab 10:290-293. (Pubitemid 20096202)
26. Schmued LC, Hopkins KJ (2000) Fluoro-Jade B: a high affinity fluorescent marker for the localization of neuronal degeneration. Brain Res 874:123-130.
27. Takizawa S, Fukuyama N, Hirabayashi H, Nakazawa H, Shinohara Y (1999) Dynamics of nitrotyrosine formation and decay in rat brain during focal ischemia-reperfusion. J Cereb Blood Flow Metab 19:667-672. (Pubitemid 30161219)
28. Cockroft KM, Meistrell M, Zimmerman GA et al (1996) Cerebroprotective effects of aminoguanidine in a rodent model of stroke. Stroke 27:1393-1398. (Pubitemid 26286174)
29. Lipton P (1999) Ischemic cell death in brain neurons. Physiol Rev 79:1431-1568. (Pubitemid 29473320)
30. Murphy S, Gibson CL (2007) Nitric oxide, ischaemia and brain inflammation. Biochem Soc Trans 35:1133-1137. (Pubitemid 350206445)
31. Ivanova S, Botchkina GI, Al-Abed Y et al (1998) Cerebral ischemia enhances polyamine oxidation: identification of enzymatically formed 3-aminopropanal as an endogenous mediator of neuronal and glial cell death. J Exp Med 188:327-340. (Pubitemid 28357761)
32. Wood PL, Khan MA, Moskal JR, Todd KG, Tanay VA, Baker G (2006) Aldehyde load in ischemia-reperfusion brain injury: neuroprotection by neutralization of reactive aldehydes with phenelzine. Brain Res 1122:184-190. (Pubitemid 44708115)
33. Giardino I, Fard AK, Hatchell DL, Brownlee M (1998) Aminoguanidine inhibits reactive oxygen species formation, lipid peroxidation, and oxidant-induced apoptosis. Diabetes 47:1114-1120. (Pubitemid 28294555)
34. Yildiz G, Demiryurek AT, Sahin-Erdemli I, Kanzik I (1998) Comparison of antioxidant activities of aminoguanidine, methylguanidine and guanidine by luminol-enhanced chemiluminescence. Br J Pharmacol 124:905-910. (Pubitemid 28312824)
35. Sun M, Zhao Y, Gu Y, Xu C (2010) Neuroprotective actions of aminoguanidine involve reduced the activation of calpain and caspase-3 in a rat model of stroke. Neurochem Int 56:634-641.
36. Di F, Yan-Ting G, Hui L et al (2008) Role of aminoguanidine in brain protection in surgical brain injury in rat. Neurosci Lett 448:204-207.
37. Nilsson BO (1999) Biological effects of aminoguanidine: an update. Inflamm Res 48:509-515.
38. Alderton WK, Cooper CE, Knowles RG (2001) Nitric oxide synthases: structure, function and inhibition. Biochem J 357:593- 615. (Pubitemid 32735142)
39. Jin K, Mao XO, Simon RP, Greenberg DA (2001) Cyclic AMP response element binding protein (CREB) and CREB binding protein (CBP) in global cerebral ischemia. J Mol Neurosci 16:49-56. (Pubitemid 32402345)
40. Jin K, Sun Y, Xie L et al (2003) Directed migration of neuronal precursors into the ischemic cerebral cortex and striatum. Mol Cell Neurosci 24:171-189. (Pubitemid 37194543)